You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 9, September 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Behavioral Neurology
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Otolaryngology/ Head & Neck Surgery
 •Olfaction and Taste Disorders
 •Alert me on articles by topic

Phantosmias and Parkinson Disease

Basile N. Landis, MD; Pierre R. Burkhard, MD

Arch Neurol. 2008;65(9):1237-1239.

Background  Impaired olfaction is a common, nonmotor manifestation of Parkinson disease (PD). However, to our knowledge, qualitative olfactory disturbances, such as odor distortions, have not been extensively reported in this condition.

Objective  To describe 2 patients who reported positive olfactory symptoms preceding typical PD, which were consistent with olfactory hallucinations (phantosmias) in the absence of major smell deficit.

Design  Case series.

Setting  University hospital.

Patients  We describe 2 patients, both seen in 2007, who reported pleasant olfactory hallucinations for several years.

Main Outcome Measures  Iodine I 123–labeled ioflupane single-photon emission computed tomography and olfactometric testing results.

Results  The 123I-labeled ioflupane single-photon emission computed tomography showed reduced radiotracer uptake in both striatum more marked in the putamen and on the left side in patient 1 and reduced radiotracer uptake in both putamen more marked on the right side in patient 2. Olfactometric testing showed mild hyposmia in patient 1 and normal function in patient 2. The disappearance of the phantosmias in both patients coincided with the development of typical PD.

Conclusion  We propose phantosmia as a new premotor manifestation of PD and suggest that qualitative abnormalities of olfaction, rather than the typical smell loss demonstrated in this condition, should be more carefully examined in the prodromal phase of PD.


Author Affiliations: Departments of Otolaryngology (Dr Landis) and Neurology (Dr Burkhard), Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.